263. Cerebrotendinous xanthomatosis Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 6 /  Drugs : 11 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 4

Cerebrotendinous xanthomatosis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
263Cerebrotendinous xanthomatosis
310Congenital anomalies syndrome
6Parkinson disease
299Cystic fibrosis
94Primary sclerosing cholangitis
46Malignant rheumatoid arthritis
67Polycystic kidney disease
84Sarcoidosis
96Crohn disease
265Lipodystrophy
93Primary biliary cholangitis
97Ulcerative colitis